NO20024247L - Pyridazinylfenylhydrazoner nyttige mot kongestiv hjertesvikt - Google Patents

Pyridazinylfenylhydrazoner nyttige mot kongestiv hjertesvikt

Info

Publication number
NO20024247L
NO20024247L NO20024247A NO20024247A NO20024247L NO 20024247 L NO20024247 L NO 20024247L NO 20024247 A NO20024247 A NO 20024247A NO 20024247 A NO20024247 A NO 20024247A NO 20024247 L NO20024247 L NO 20024247L
Authority
NO
Norway
Prior art keywords
pyridazinylphenylhydrazones
useful
heart failure
congestive heart
congestive
Prior art date
Application number
NO20024247A
Other languages
English (en)
Other versions
NO324172B1 (no
NO20024247D0 (no
Inventor
Jarmo Pystynen
Aino Pippuri
Anne Luiro
Pentti Nore
Reijo Baeckstroem
Kari Loennberg
Heimo Haikala
Jouko Levijoki
Petri Kaheinen
Juha Kaivola
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20024247D0 publication Critical patent/NO20024247D0/no
Publication of NO20024247L publication Critical patent/NO20024247L/no
Publication of NO324172B1 publication Critical patent/NO324172B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20024247A 2000-03-13 2002-09-05 Pyridazinylfenylhydrazoner nyttige mot kongestiv hjertesvikt NO324172B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000577A FI20000577A0 (fi) 2000-03-13 2000-03-13 Pyridatsinyylifenyylihydratsoneja
PCT/FI2001/000241 WO2001068611A1 (en) 2000-03-13 2001-03-12 Pyridazinyl phenyl hydrazones useful against congestive heart failure

Publications (3)

Publication Number Publication Date
NO20024247D0 NO20024247D0 (no) 2002-09-05
NO20024247L true NO20024247L (no) 2002-10-25
NO324172B1 NO324172B1 (no) 2007-09-03

Family

ID=8557913

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024247A NO324172B1 (no) 2000-03-13 2002-09-05 Pyridazinylfenylhydrazoner nyttige mot kongestiv hjertesvikt

Country Status (32)

Country Link
US (1) US6699868B2 (no)
EP (1) EP1265871B1 (no)
JP (1) JP2003527375A (no)
KR (1) KR20030001379A (no)
CN (1) CN1191241C (no)
AR (1) AR027644A1 (no)
AT (1) ATE317388T1 (no)
AU (2) AU4657701A (no)
BG (1) BG65859B1 (no)
BR (1) BR0109136A (no)
CA (1) CA2403188A1 (no)
CZ (1) CZ20022997A3 (no)
DE (1) DE60117131T2 (no)
DK (1) DK1265871T3 (no)
EA (1) EA005574B1 (no)
EE (1) EE200200520A (no)
ES (1) ES2256222T3 (no)
FI (1) FI20000577A0 (no)
HK (1) HK1052008A1 (no)
HR (1) HRP20020816A2 (no)
HU (1) HUP0300177A3 (no)
IL (2) IL151492A0 (no)
MX (1) MXPA02008997A (no)
NO (1) NO324172B1 (no)
NZ (1) NZ521162A (no)
PL (1) PL357107A1 (no)
RS (1) RS50439B (no)
SI (1) SI1265871T1 (no)
SK (1) SK287163B6 (no)
UA (1) UA74571C2 (no)
WO (1) WO2001068611A1 (no)
ZA (1) ZA200206917B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015228D0 (en) * 2000-06-21 2000-08-16 Portela & Ca Sa Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders
JP4561698B2 (ja) * 2002-02-19 2010-10-13 小野薬品工業株式会社 縮合ピリダジン誘導体化合物およびその化合物を有効成分として含有する薬剤
JPWO2004087641A1 (ja) * 2003-03-31 2006-06-29 第一製薬株式会社 ヒドラゾン誘導体
GB0503962D0 (en) 2005-02-25 2005-04-06 Kudos Pharm Ltd Compounds
EP2492263A1 (en) 2006-07-25 2012-08-29 Cephalon, Inc. Pyridizinone Derivatives
AU2008206903B2 (en) * 2007-01-17 2012-07-05 Orion Corporation Levosimendan for use in treating chronic valvular disease
EP2762465B1 (en) * 2011-09-27 2018-01-10 Zeon Corporation Intermediate for manufacture of polymerizable compound and process for manufacture thereof
CA2898440A1 (en) * 2013-01-18 2014-07-24 Bristol-Myers Squibb Company Phthalazinones and isoquinolinones as rock inhibitors
EP3804707A4 (en) * 2018-06-08 2022-03-16 Nissan Chemical Corporation KINASE INHIBITORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531658A1 (de) 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
HUP0300177A3 (en) 2003-09-29
SI1265871T1 (sl) 2006-06-30
BG65859B1 (bg) 2010-03-31
EA200200973A1 (ru) 2003-02-27
IL151492A (en) 2007-09-20
EP1265871A1 (en) 2002-12-18
CZ20022997A3 (cs) 2003-04-16
US20030158200A1 (en) 2003-08-21
UA74571C2 (en) 2006-01-16
WO2001068611A1 (en) 2001-09-20
PL357107A1 (en) 2004-07-12
DE60117131T2 (de) 2006-10-26
DK1265871T3 (da) 2006-06-06
SK12882002A3 (sk) 2003-06-03
DE60117131D1 (de) 2006-04-20
CN1191241C (zh) 2005-03-02
US6699868B2 (en) 2004-03-02
EP1265871B1 (en) 2006-02-08
NO324172B1 (no) 2007-09-03
AU4657701A (en) 2001-09-24
KR20030001379A (ko) 2003-01-06
AU2001246577B2 (en) 2006-08-31
BR0109136A (pt) 2002-12-24
SK287163B6 (sk) 2010-02-08
YU68502A (sh) 2005-11-28
IL151492A0 (en) 2003-04-10
EE200200520A (et) 2004-04-15
NO20024247D0 (no) 2002-09-05
ATE317388T1 (de) 2006-02-15
CN1418196A (zh) 2003-05-14
JP2003527375A (ja) 2003-09-16
MXPA02008997A (es) 2003-04-25
ZA200206917B (en) 2003-07-30
RS50439B (sr) 2009-12-31
CA2403188A1 (en) 2001-09-20
BG107175A (bg) 2003-05-30
FI20000577A0 (fi) 2000-03-13
EA005574B1 (ru) 2005-04-28
HK1052008A1 (en) 2003-08-29
NZ521162A (en) 2003-11-28
HUP0300177A2 (hu) 2003-07-28
AR027644A1 (es) 2003-04-09
ES2256222T3 (es) 2006-07-16
HRP20020816A2 (en) 2004-12-31

Similar Documents

Publication Publication Date Title
NO20031331D0 (no) Substituerte amino-aza-cykloalkaner anvendelige mot malaria
BR0116612B1 (pt) estrutura laminada.
DE60028410D1 (de) Plattenlaufwerk
ATE346418T1 (de) Wechselrichter
DE60133295D1 (de) Sulphoniumsalz-verbindung
DE50102748D1 (de) Antriebseinheit
NO20026196L (no) Kinazolinditosylatsalt-forbindelser
DE10197104T1 (de) Hybridantriebssystem
EE200200475A (et) Arüülkondenseerunud asapolütsüklilised ühendid
NO20002572D0 (no) Flerlags-struktur
NO20025602D0 (no) Tettet sideforbindelse i borehull
NL1015211A1 (nl) Aandrijving.
DE60014226T8 (de) Laminiervorrichtung
DE60037233D1 (de) Hämofiltrationsvorrichtung
DE60137387D1 (de) Verbindungsstruktur
DK1078445T3 (da) Vekselretter
FI20000510A (fi) Taajuusmuuttaja
NO20021815D0 (no) Forbindelse
NO20013769D0 (no) Kalsilytiske forbindelser
NO20024247D0 (no) Pyridazinylfenylhydrazoner nyttige mot kongestiv hjertesvikt
NO20032255L (no) Dehalogen-forbindelser
NO20023976D0 (no) Endoparasittisidisk middel
NO20030303L (no) Kalsilytiske forbindelser
NO20031837D0 (no) Kalsilytiske forbindelser
NO20023508L (no) Kalsilyttiske forbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees